HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer (Q33688043)

28 July 2017

title

HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer (English)

1 reference

28 July 2017

11

Arnulf Stenzl

1 reference

28 July 2017

Mario W Kramer

1

1 reference

28 July 2017

Roozbeh Golshani

2

1 reference

28 July 2017

Axel S Merseburger

3

1 reference

28 July 2017

Judith Knapp

4

1 reference

28 July 2017

Alfredo Garcia

5

1 reference

28 July 2017

Joerg Hennenlotter

6

1 reference

28 July 2017

Robert C Duncan

7

1 reference

28 July 2017

Mark S Soloway

8

1 reference

28 July 2017

Merce Jorda

9

1 reference

28 July 2017

Marcus A Kuczyk

10

1 reference

28 July 2017

Vinata B Lokeshwar

12

1 reference

28 July 2017

language of work or name

English

0 references

publication date

31 March 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

86-93

1 reference

Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Hyaluronan and hyaluronidase in genitourinary tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Molecular risk assessment for breast cancer development in patients with ductal hyperplasias

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Nomograms for bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Tissue microarrays in clinical urology--technical considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

HAS1 expression in bladder cancer and its relation to urinary HA test.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828527

Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade

30 October 2018

1 reference

12 December 2020

Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin

1 reference

12 December 2020

High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer

1 reference

12 December 2020

Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer

1 reference

12 December 2020

Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests

1 reference

12 December 2020

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer

1 reference

12 December 2020

Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1

1 reference

12 December 2020

Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer

1 reference

12 December 2020

Molecular markers in bladder cancer

1 reference

12 December 2020

10.1016/J.EURURO.2009.03.057

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference